Chemoinformaics analysis of 3,7-Dimethyloctan-3-ol
| Molecular Weight | 158.285 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 4 |
| Exact Molecular Weight | 158.167 | nRing | 0 |
| Solubility: LogS | -6.187 | nHRing | 0 |
| Solubility: LogP | 7.066 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 32.1714 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.366 |
| Synth | 2.869 |
| Natural Product Likeliness | 0.958 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.026 |
| Pgp-sub | 0 |
| HIA | 0.005 |
| CACO-2 | -4.859 |
| MDCK | 0.000025 |
| BBB | 0.023 |
| PPB | 0.993019 |
| VDSS | 0.815 |
| FU | 0.00694834 |
| CYP1A2-inh | 0.243 |
| CYP1A2-sub | 0.208 |
| CYP2c19-inh | 0.198 |
| CYP2c19-sub | 0.182 |
| CYP2c9-inh | 0.237 |
| CYP2c9-sub | 0.989 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.091 |
| CYP3a4-inh | 0.12 |
| CYP3a4-sub | 0.033 |
| CL | 2.887 |
| T12 | 0.488 |
| hERG | 0.061 |
| Ames | 0.004 |
| ROA | 0.012 |
| SkinSen | 0.936 |
| Carcinogencity | 0.051 |
| EI | 0.957 |
| Respiratory | 0.843 |
| NR-Aromatase | 0.084 |
| Antiviral | No |
| Prediction | 0.855933 |